Minor Use Minor Species Development of Drugs
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.
About
Drug companies rarely bother developing a new drug for a rare animal disease or an uncommon species, because the market is too small to cover the cost of the safety and effectiveness testing FDA approval requires.
This is FDA's Center for Veterinary Medicine (CVM) reimbursing the cost of that testing for animal drugs designated under the Minor Use Minor Species (MUMS) programme — drugs for minor …
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.